Tremfya Leads TV Pharma Ads in September and Q3
Johnson & Johnson's Tremfya retained its top position for TV pharma brand ad impressions in September, with a 5.02% share of voice and 3.1 billion impressions, following a $32.8 million ad spend.
- Tremfya's ad spend increased by approximately $10 million compared to August.
- The brand's impressions primarily came from Univision's ¡Despierta América!
Vicks took the second place, pushing AbbVie's Skyrizi to third, with a 4.71% impressions share of voice and 2.9 billion impressions, mainly through CBS and GMA 3: What You Need to Know, after investing $10.3 million in TV ads.
No specific quote available in the text.
In summary, college football and Spanish language TV drove most TV pharma ad impressions in September.
Author's summary: Tremfya leads TV pharma ads.
More News
- Columbia Blacktails Are the Toughest Deer to Hunt
- Armenian Ambassador Lauds Ethiopia's Transformative Economic Reform, Corridor Dev’t
- Gallery | Sunderland 2-0 Wolves
- Knicks’ harsh Mitchell Robinson reality could open the door for a surprise breakout
- Events this weekend (Oct. 17–19)
- Marines Corps live-fire event at Camp Pendleton to close down large stretch of coastal freeway
- Party is on verge of ‘a historic breakthrough’ says Scottish Lib Dem leader
- BGPD announces downtown street closures
- Ants ‘social distance’ during a pandemic